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Pregnancy is the distinctive nature of a particular order in which related things follow 
each other of effective physiological changes that a marked effect on various organs 
function and is associated with multiple changes in respiratory system anatomy and 
physiology1-3. Three important changes in the organization of the thorax that occur 
during the period of pregnancy were an expansion in the width of the lower-level of 
chest wall (anteroposterior and the transverse diameters are increased); raise of the 
diaphragm (a cephalad displacement of approximately 4 cm to 5 cm) and a 50% 
broadening of the costal angle1-3. These alterations attain the maximum around the 
37th week of pregnancy and become normal within 6 months after delivery6. 
Pulmonary function is disturbed by changes in the airway, thoracic cage, and 
respiratory drive. And also capillary engorgement in the entire respiratory tract leads 
to mucosal edema and hyperemia4,5. Multiple biochemical changes like increase in 
progesterone, estrogen, prostaglandins, corticosteroid and cyclic nucleotide levels 
occur simultaneously during the period of pregnancy6. The chest wall circumference 
raised about 6cm but not satisfactorily to present a marked dimnision in the Residual 
Volume of air in the lungs controlled by the raised diaphragm. The Diaphragmatic 
elevation is literally greater during pregnancy than during nonpregnant state6. During 
any level of normal pregnancy, the amount of oxygen entered into the lungs, by the 
rise in Tidal Volume in a clear manner go beyond the oxygen need to be forced by 
pregnancy. Furthur more the quantity of hemoglobin in circulation raises as a result of 
an effect of the maternal arteriovenous oxygen difference. Pregnancy is related with 
physiological adaptation in the control of breathing, in lung volumes, in the 
mechanisms of respiration and in acid-base balance. Maternal pulmonary changes in 
succession alter the metabolism and health of the fetus through their influence on 
placental gas exchange6. The most important changes in lung function is a rise in 
Minute Ventilation which enhances by 36% by the eighth week of antenatal period 
finally attaining the levels ,50% above the nonpregnant demand. These changes are 
needed to fulfill the increase in oxygen consumption of 30-35% by the growing 
fetus6. The respiratory alterations have far-reaching clinical implications as previous 
knowledge will aid significantly in the process of dealing with an antenatal women 
with respiratory disorders. Pulmonary alterations in antenatal period are of clinical 
significance to the anesthetist during management of anesthesia to antenatal women, 
especially during caesarean section6. Thus this study objective is specifically 
evaluating some ventilatory function changes as they affect normal antenatal women 
in different trimesters. 
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INTRODUCTION 
 
Pregnancy is the distinctive nature  of a particular order in which related things 
follow each other of effective physiological changes that a marked effect  on various 
organs function and is associated with multiple changes in respiratory system anatomy 
and physiology1-3. Three important changes in the organization of the thorax that occur 
during the period of pregnancy were an expansion in the width of the lower-level of chest 
wall (anteroposterior and the transverse diameters are increased); raise of the diaphragm 
(a cephalad displacement of approximately 4 cm to 5 cm) and a 50% broadening of the 
costal angle1-3. These alterations attain the maximum around the 37th week of pregnancy 
and become normal within 6 months after delivery6.  
Pulmonary function is disturbed by changes in the airway, thoracic cage, and 
respiratory drive. And also capillary engorgement in the entire respiratory tract leads to  
mucosal edema and hyperemia4,5. Multiple biochemical changes like increase in 
progesterone, estrogen, prostaglandins, corticosteroid and cyclic nucleotide levels occur 
simultaneously during the period of pregnancy6. 
The chest wall circumference raised about 6cm but not satisfactorily to present a 
marked dimnision in the Residual Volume of air in the lungs controlled by the raised 
diaphragm. The Diaphragmatic elevation is literally greater during pregnancy than during 
nonpregnant state6. During any level of normal pregnancy, the amount of oxygen entered 
into the lungs, by the rise in Tidal Volume in a clear manner go beyond  the oxygen need 
to be forced by pregnancy. Furthur more the quantity of hemoglobin in circulation raises 
as a result of an effect of the maternal arteriovenous oxygen difference. Pregnancy is 
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related with physiological adaptation in the control of breathing, in lung volumes, in the 
mechanisms of respiration and in acid-base balance. Maternal pulmonary changes in 
succession alter the metabolism and health of the fetus through their influence on 
placental gas exchange6. 
The most important changes in lung function is a rise in Minute Ventilation which 
enhances by 36% by the eighth week of antenatal period finally attaining the levels ,50% 
above the nonpregnant demand. These changes are needed to fulfill the increase in 
oxygen consumption of 30-35% by the growing fetus6.  
 The respiratory alterations have far-reaching clinical implications as previous 
knowledge will aid significantly in the process of dealing with an antenatal women with 
respiratory disorders. Pulmonary alterations in antenatal period are of clinical 
significance to the anesthetist during management of anesthesia to antenatal women, 
especially during caesarean section6.  
 Thus this study objective is specifically evaluating some ventilatory function 
changes as they affect normal antenatal women in different trimesters. 
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AIM AND OBJECTIVES OF THE STUDY 
 
AIM:   
To determine the effect of pregnancy on pulmonary function parameters in antenatal 
cases attending Karpaga Vinayaga Institute Medical Sciences and Research Centre, 
Kancheepuram District. 
 
OBJECTIVES:  
x To establish the values of Forced Vital Capacity (FVC) in Pregnancy 
x To establish the values of Forced Expiratory Volume (FEV1) in Pregnancy 
x To verify the difference in FEV1/FVC during Pregnancy 
x To evaluate the values Peak Expiratory Flow Rate (PEFR) during Pregnancy  
x To assess the effect of gestational age (1st ,  2nd and  3rd trimester) on these 
parameters 
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REVIEW OF LITERATURE 
The pulmonary system includes the lungs, the conducting airways that direct air 
to the gas exchange sites (alveoli), respiratory centers in the central nervous system, the 
muscles of the chest wall and the diaphragm that are responsible for inflation and 
deflation of the lungs7. The lungs occupy most of the thoracic cavity except for the space 
filled by the heart and major blood vessels7. 
The process of respiration is divided into four categories: 1- Pulmonary ventilation. 2- 
Diffusion of oxygen and CO2 between alveoli and tissues. 3- Transport of oxygen and 
CO2 in body fluids to and from cells. 4- Regulation of respiration.7 
Air is distributed to alveoli as a result of contraction of the respiratory muscle. 
These muscles comprise the diaphragm and the external intercostal muscles of the 
ribcage and accessory inspiratory muscles (scalenes and sternocleidomastoids which are 
not active in eupnea). Contraction of these muscles expands the thoracic cavity, creating 
a subatmospheric pressure in the alveoli. Contraction of the diaphragm results in 
downwards displacement of the thoracic cavity and contraction of external intercostals 
muscles resulting in a lifting of the thoracic cage leading to increasing in the 
anteroposterior diameter. As alveolar pressure decreases, atmospheric air enters into the 
alveoli by bulk flow till the pressure becomes equal. The process of filling up the lung is 
called inspiration. Expiration is generally passive, results from relaxation of the 
inspiratory muscles and powered by elastic recoil of lung tissue that is stretched during 
inspiration. With the relaxation of the inspiratory muscles and lung deflation, alveolar 
pressure overreaches atmospheric pressure, so gasses flow from the alveoli to the 
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atmosphere by bulk flow. Active expiration is because of internal intercostals muscles 
and the abdominal recti muscles7. 
 
 
Pulmonary ventilation includes the inflow and outflow of air in the lungs,which is 
altered by various independent factors.  Spirometry is a method of assessing lung 
function by measuring the volume of air that the patient can expire from the lungs after a 
maximal inspiration. 
Lung Volumes and Capacities 
spirometry measurement of Lung volumes is fundamentally anatomical measurements of 
lung gas volumes. A lung volume refers to a principle volume of the lung, whereas lung 
capacities, also a volume measurement, are the sum of two or more principle lung 
volumes. The following lung volumes can be measured directly or indirectly with a 
spirometer7: 
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Tidal Volume (VT): volume of air inhaled or exhaled during a normal spontaneous 
breath. 
Inspiratory Reserve Volume (IRV): volume of air that can be inhaled at the end of a 
spontaneous inspiration. 
Expiratory Reserve Volume (ERV): volume of air that can be exhaled at the end of a 
spontaneous VT. 
Residual Volume (RV): volume of air in  lungs that cannot be forcefully exhaled or the 
volume of air in the lung at end of a vital capacity. 
 
Vital Capacity (VC): maximum volume of air that can be exhaled after a maximal 
inspiration or IRV + VT + ERV. 
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Inspiratory Capacity (IC): the maximal volume of air that can be inhaled from normal 
end-expiration or VT + IRV 
Functional Residual Capacity (FRC): total volume of air in the lung at end of normal 
end-expiration or ERV + RV. 
Total Lung Capacity (TLC): total volume of air in lung at maximal endinspiration or 
VC + RV or IRV + VT + ERV + RV. 
The minute respiratory volume: Total amount of new air moved into the respiratory 
passages per minute and is equal to tidal volume (500 ml) multiplied by the respiratory 
rate (12/min) = 6000ml/minute. 
SPIROMETRY:- 
Spirometry is a physiological test that estimates how an individual inspires or 
expires volumes of air as a function of time. The basic signal estimated in spirometry 
may  be  volume  or  flow.  Spirometry  is  extremely  useful  as  a  screening  test  of  general  
respiratory health in the same way that blood pressure gives crucial information about 
general cardiovascular health. However, on its own, spirometry does not lead clinicians 
directly to an aetiological diagnosis8,9.  
Spirometry has many other applications in evaluating and governing respiratory 
disease. These include estimating the presence and severity of restrictive lung diseases, 
screening of the employees in hazardous occupational environments, pre-employment 
screening for definite occupations, and evaluating fitness to work. Some believe it may 
be helpful as an encouraging tool to help smokers to quit, but solid scientific evidence on 
this point is lacking at present, and research findings have been equivocal8,9. 
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Spirometry can be done with many different types of equipment and involves 
cooperation between the subject and the examiner, and the results got will depend on 
technical as well as personal factors.8,9 
If the quality of uneven results can be decreased and the estimation accuracy can 
be improved, the range of normal values for populations can be narrowed and alterations 
more easily observed. The  first American Thoracic Society (ATS) statement on the 
standardization of spirometry as the consequence of The Snowbird workshop held in the 
year 197910 . This was upgraded in 1987 and again in 199411, 12. The  European 
Community have taken a similar initiative  for Steel and Coal, resulting in the first 
European standardization document in 198313. This was then updated in  
1993 as the official statement of the European Respiratory Society (ERS)14. There 
are usually only minor differences between the two most recent ATS and ERS 
statements, except that the ERS statement includes absolute lung volumes and the ATS 
does not. The  ATS and ERS together in an attempt to publish standards that can be 
applied more widely. The statement is designed to cover definitions, equipment, and 
patient-related procedures. All recording devices covered by this statement must meet the 
appropriate requirements, despite whether they are for monitoring or diagnostic purposes. 
There is no separate category for ‘‘monitoring’’ devices9. 
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TYPES OF SPIROMETERS: - 
 
Bellows or rolling seal spirometers are big and not easily transportable, and are used 
mainly in lung function laboratories. They require regular calibration with a 3-liter 
syringe and are very accurate9. 
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Electronic desktop spirometers are small, easily transportable, and generally fast and 
easy to use. They have a real-time visual display and paper or computer printout. Some 
need calibration with the 3-liter syringe; others can be examined for accuracy with the 
syringe but necessitates any alterations to be executed by the manufacturer. Usually, they 
require small observation other than cleaning. They sustain validity over years and are 
perfect for primary care9. 
 
 
Small, inexpensive hand-held spirometers give a numerical record of blows but no 
printout. It may be important to look up predicted values in tables, but some include these 
in their built-in software. Recent new models allow pre-programming of  details about the 
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patient so that the spirometer also gives percent predicted values. These are useful for 
simple screening and are precise for diagnosis if the more costly desktop form is 
unsuitable or too expensive9. 
 
Many  spirometers  give  two  forms  of  traces.  One  is  the  standard  plot  of  volume  
expired against time. The other is a plot of flow (L/sec) on the vertical axis versus 
volume expelled (L) on the horizontal axis. This is a flow–volume trace and is most 
helpful in diagnosing airway obstruction9. 
In some countries, a printed record of spirometry is necessary for claiming 
insurance/practitioner reimbursement. The type of spirometer to be used may need to  
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think careful in the light of this, as some automatically produce a printout, others can 
store data to be printed later from a PC, and others do not have printing capacity at all8,9. 
 
SPIROMETRY INDICES:- 
Forced Vital Capacity (FVC): - 
This is the volume change between maximal inhalation and maximal exhalation. 
It can be measured during normal inhalation and exhalation or during forced 
 ventilatory effort (FVC). FVC measures about 4.8 liters in males and 3.7 liters in 
females8,9. 
 
Forced Expiratory Volume in one second (FEV1): - 
FEV1 is the volume of air expired during the first one second of exhalation 
maneuver starting from total lung capacity (TLC).It is the very often used index to assess 
airway obstruction, bronchodilation, and constriction of airways. The FEV1 should be 
more than 80% of the predicted value for age, race, and height is normal8,9.  
 
FEV1/FVC% : - 
When expressed as the percentage of VC (FEV1 percentage FVC), it is an index 
of evaluating and quantifying airflow limitation. In patients with obstructive lung disease, 
the IVC is more than the EVC, which is more than FVC. Thus when using the 
FEV1/FVC ratio as an index, the actual VC should be specified; hence 
FEV1percentageFVC or FEV1percentageIVC. The normal ratio of FEV1/ FVC is 0.8 to 
18,9. 
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Expiratory Peak Flow Rate (PEFR): - 
This is the maximum flow generated during expiration performed with maximal 
force and started after a full inspiration. PEFR is appreciably larger if the maneuver is 
performed without pause, immediately after the inspiration than if it is performed after a 
pause. The normal value is between 250 and 450litres /minute8,9. 
 
 
Several factors decide the value of respiratory parameters. These variations occur 
from one geographical location to the other, and even within the same population. 
Furthermore, other socio-demographic and anthropometric factors influence results. The 
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relationship between some respiratory parameters with age, weight, height race etc has 
been established.  
 
Pregnancy leading to some physiological and biochemical alterations that 
influence generally all the organ of the  body. Indeed, the alterations in the pulmonary 
system have far-reaching implications for the antenatal woman, her baby, and health care 
providers6.  
The nasal obstruction is related with clear rhinorrhea and physical examination of 
nose shows edematous nasal mucosa. It is known to be caused by a number of related 
factors. The  nasal mucosa is affected by a generalized rise in interstitial fluid volume 
seen during the antenatal period and is also made worse by the direct effect of estrogen 
on the nasal mucosa, which causes increased vascularity and mucosal oedema16. 
 Pregnancy-induced hypertension (PIH) or preeclampsia can  increase the 
symptoms of nasal obstruction by fluid overload or edema. In PIH or Pre-eclampsia, 
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manipulation of the airway can lead to massive bleeding from the nose or oropharynx; 
endotracheal intubation can be a difficult one, and only a smaller than usual endotracheal 
tube may fit through the larynx17-19. 
There have been a lot of alterations and important advances in pulmonary 
function testing, but little has been applied to antenatal women particularly in our 
environment and it is hoped that our work in this area will help to refine the situation. 
Hyperventilation occurs during the antenatal period. The attendant hypocapnia and 
alkalosis of results from a complex interaction of pregnancy, induced changes in 
wakefulness and central chemoreflex drive to breathe, acid-base balance, metabolic rate, 
and cerebral blood flow19 . There had been a lot of controversy surrounding the effects of 
pregnancy on vital capacity with many conflicting results.  
Puranik et al, working in India, evaluated pulmonary function status in fifty 
normal pregnant women tested monthly. The parameters studied were Vital Capacity 
(VC), Forced Vital Capacity (FVC) and Forced Expiratory Volume in 1st second (FEV1) 
using Vitalograph Spirometer; tidal volume (VT), inspiratory capacity (IC) and 
expiratory reserve volume (ERV) using spirograph and resting minute ventilation (VE) 
using Tissot's spirometer. Control values were obtained in the same subject 8-10 weeks 
after delivery. The increment seen in VT, VE and IC was very highly remarkable20. The 
small increase in the frequency of respiration was important and the decreasing trend 
noticed in ERV was very highly noteworthy. VC and FVC were conserved by the 
increase in IC and an associated decline in ERV. An  increase  in VC is caused  mainly to 
increase in VT than the increase in frequency20.  
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Another study in India using a dry bellows spirometer and a Wright's peak flow 
meter showed a marked decline in peak expiratory flow rate, forced vital capacity and 
forced expiratory volume in one second during the third trimester compared to controls21.  
Chhbra et al. study, 70 selected women, 50 pregnant and 20 nonpregnant controls 
found that out of seven parameters studied five showed alterations. There were alterations 
in the frequency of respiration, tidal volume, vital capacity, inspiratory capacity and 
expiratory reserve volume22. Maximum voluntary ventilation and timed vital capacity did 
not change. RF, VT, VC and IC increased significantly while a significant decline of 
ERV. These alterations may  affect the antenatal behavior of pregnant women and their 
pregnancy outcomes22. 
Kolarzyk, working in Poland on 51 antenatal women aged 26.6±4.9 years and 40 
healthy women (control group), showed a statistically significant increase during the 
antenatal period in cases of tidal volume (VT) and minute ventilation (MV) (whereas 
breath frequency was nearly on the same level)23.There were also differences in 
inspiratory drive (VT/TI), occlusion pressure (P0.1), RRS. In addition, there was a 
correlation between BMI at the baseline with P0.1, MV, and VT/TI23.  
Sroczynski examined the function of the respiratory system in antenatal women in 
the last month of non-complicated pregnancy. Spirometry with Lung test 1000 was 
performed in 31 antenatal women at a mean gestational age of 37.72 weeks. In 24 of 
them, the test was repeated after delivery24 .The results were compared with a control 
group of 31 healthy non-pregnant women. The vital capacity in the last month of 
pregnancy did not differ from values after delivery and in the control group. Component 
volumes changed: tidal volume was increased, expiratory reserve volume decreased, and 
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inspiratory reserve volume remained unchanged24. Minute ventilation recorded  at rest in 
antenatal period is raised despite lowered breathing rate, whereas maximum voluntary 
ventilation was lower than after delivery and in the control group, evidencing decreased 
breathing reserve. The main forced expiratory parameters continue to exist unchanged in 
pregnancy. Parameters characterizing bronchioles showed an increase in airflow 
(bronchodilation). Furthermore, dyspnoeic symptoms found in antenatal women 
correlated with alterations in vital capacity components. Symptoms depended on the 
mechanics of ventilation and not on the status of bronchi24. 
Rees measured some respiratory parameters longitudinally during pregnancy and 
post partum in 20 normal subjects with a computer-assisted mass spectrometer25. It 
showed that resting tidal volume, minute ventilation, oxygen consumption, and carbon 
dioxide production raised during pregnancy. End-tidal carbon dioxide tension fell 
continuously during  the antenatal period. Respiratory exchange ratio was 0.9 at 36 to 39 
weeks' gestation and 0.8 at 5-13 weeks postpartum. Ventilatory frequency did not alter 
during the antenatal period25.   Wise and colleagues (1992) in the USA observed that the 
important physiologic changes that occur during antenatal period are the increased 
minute ventilation, which is caused by enhanced respiratory center sensitivity and drive; 
a compensated respiratory alkalosis; and a low expiratory reserve volume. The vital 
capacity and measures of forced expiration are well preserved. Patients who have many 
lung diseases tolerate pregnancy well, with the exception of those who have pulmonary 
hypertension or chronic respiratory insufficiency from a parenchymal or neuromuscular 
disease.  
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 Lui  measured the lung functions in different pregnant stages in 41 women with 
pregnancy and 12 normal women without pregnancy. Forced Vital Capacity (FVC) 
significantly, but gradually decreased as pregnancy advanced26.  After  28  weeks  of  
gestation, the Vital Capacity (VC), Forced Expired Volume in 1 second (FEV1) 
significantly declined as compared with the normal values. These results suggested that 
the lung function altered gradually during pregnancy, especially after the 28th week, but 
more significantly in VC, FVC, and FEV1. Maybe there are slight obstructions in the 
bronchial tubes, after the 28th week of gestation and it may be the reason for the 
occurrence of shortness of breath and the lung infection26. 
Peak expiratory flow rate has exhibited variations during the antenatal period. 
Peak expiratory flow rates (PEFR) were measured longitudinally in 60 pregnant women 
aged 20-28 years (average 24 yrs), with the height between 130-160 cm (average 154.5 
cm), each month beginning from 3rd month of gestation and also 8-10 weeks postpartum 
using Wright's Peak Flow Meter. The PEFR decreased from 329.12 +/- 4.40 lpm in the 
3rd month to 286.22 +/- 3.81 lpm in the 9th month of gestation and risen to 347.86 +/- 
2.93 lpm in postpartum period20. However Brancazio, study longitudinally in the USA on 
57 women during each trimester of pregnancy and postpartum demonstrated that peak 
expiratory flow rate does not change with pregnancy and advancing gestation27. This 
finding is in agreement with a recent study in Northern Nigeria using 250 female (123 
pregnant and 127 non-pregnant).Although values obtained were lower than that of 
Caucasians, there were no significant changes between pregnant and non-pregnant 
subjects 28. The Pulmonary function does not seem to be affected by fundal height or 
number of fetuses.  
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A cross-sectional study of pulmonary function was performed in 68 women with 
twin pregnancies (17 examined in the first trimester, 35 second trimester, 16 third 
trimester) and 140 women with singleton pregnancies (28, 80, 40, respectively) and 22 
non-pregnant women in a London teaching hospital. In both the twin and singleton 
pregnancies, the mean FRC and expiratory reserve ventilation of women studied in the 
third trimester and minute ventilation of women studied in each trimester differed 
significantly from that of the non-pregnant women. There were, however, no significant 
differences demonstrated in respiratory function between healthy women with a twin as 
compared with singleton pregnancies29. Moreover , Strauss studied, retrospectively, 
carried out 69 spirometric pulmonary function tests on 19 singletons, seven twins, 38 
triplets, and five quadruplet pregnancies; maternal age 19–37 years; pregnancy weeks 
22–4130.The  vital capacity forced expired volume in 1 second, Tiffeneau's index, blood 
gasses as well as blood pH levels were not significantly different in singleton, twin, 
triplet or quadruplet pregnancies before or after 30 weeks of gestation. Finally, no 
significant difference in respiratory function measurements could be found between 
higher order pregnancies with or without subjective dyspnea. Thus, no clinically relevant 
correlation between any spirometrically measurable pulmonary function values and 
pregnancy data referring to uterine size, fundal height or breathlessness were found30. 
Various physiological and pathological conditions may affect lung function during 
pregnancy. A study performed by Schultz et al. in Denmark showed a significant 
decrease in FRC, PEFR and FEV1 because of the postural changes, however, arterial 
oxygenation, MVV, and DLCO remained largely the same. 
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In Switzerland, it has been shown that epidural analgesia improves lung 
function31. Spirometry was performed in sixty consenting participants receiving epidural 
analgesia during the antepartum visit and in labour. After effective epidural analgesia was 
established; at both assessments and the women were pain-free the results were as 
follows: Values were within normal ranges but increased significantly after effective 
epidural analgesia; median inter quantan range (IQR)) increase for vital capacity 7.4 (3.0-
13 [-12- 27])% , forced vital capacity 4.4 (1.7-9.8 [-13-26])% ; forced expiratory volume 
in 1 s 5.5 (1.7-8.6 [-14-28])% ; and peak expiratory flow rate 2.3 (-1.6-5.8 [-18-16])%31. 
Unsal measured FVC, FEV1 and PEFR in 13 pre-eclamptic and 15 control 
subjects undergoing cesarean section31; and 11 pre-eclamptic and 15 control subjects 
undergoing vaginal delivery (VD) on the postpartum third day. It was demonstrated that 
certain pulmonary functions might be impaired in the early postpartum period in pre-
eclamptic women undergoing a caesarean section. Preeclamptic women had significantly 
lower FVC, FEV1 and PEFR measurements than the control. When the subjects were 
grouped according to the mode of delivery, FVC, and FEV1 values were observed to be 
significantly different between the preeclamptic and control groups undergoing a 
caesarean section.None of these parameters was significantly different between the pre-
eclamptic and control groups who had delivered vaginally31. Lung function is affected by 
multifactorial variables including normal pregnancy. These changes are further modified 
by some obstetrics complications. Thus, baseline values are extremely invaluable in the 
management of pregnant women with obstetric and pulmonary complications. 
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MATERIALS AND METHODS 
 
STUDY DESIGN:  
Observational Study 
 
STUDY SETTING:  
Antenatal women attending the obstetric and gynecology  Department of  
Karpaga Vinayaga Institute of Medical Sciences and Research Centre, 
Chinnakaolambakkam, Kancheepuram district 
STUDY PERIOD:  
April 2015 to January 2016 
 
POPULATION AND SAMPLING: 
The antenatal mothers visiting OBG department were taken for the study after 
getting informed consent, the consent being explained in their own language. The 
subjects were grouped into three: Pregnant subjects of first trimester (up to12 weeks), 
second trimester (13 weeks to 28 weeks) and third trimester (29weeks to up to birth) 
gestational period. Totally 90 samples, (i.e) 30 subjects in each group were selected for 
this study by purposive sampling technique.  
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ETHICAL CLEARANCE:  
 Ethical clearance (Reg No: 201415601) was obtained from Institutional Ethical 
Committee, Karpaga Vinayaga Institute of Medical Sciences and Research Centre. 
 
INCLUSION CRITERIA 
x  Confirmed pregnant women who were willing to participate 
x Ability to demonstrate sufficient proficiency in carrying out the tests needed to 
assess ventilatory function. 
EXCLUSION CRITERIA 
Patients with the following were excluded: 
x Pre-existing cardio-respiratory diseases like asthma, Chronic Obstructive Airway 
Disease (COPD), Congestive Cardiac Failure (CCF). 
x Presence of spinal deformities (scoliosis, kyphoscoliosis) 
x Upper and lower respiratory tract infections. 
x Medications that alter lung function (e.g. bronchodilators and constrictors). 
x Acute malaria in pregnancy. 
x Pre-eclampsia. 
x Diabetes in pregnancy 
x Other pregnancy complications (threatened abortion, antepartum hemorrhage etc) 
We have used computer-based spirometry,  Medicaid spiro excel in performing 
pulmonary function test for the study participants in this study. 
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METHODOLOGY: 
The subjects considered for this study are with Hemoglobin more than 10 gm%. 
All the subjects were called for spirometric tracings, 3 to 4 hrs after meal, in the post 
absorption stage in order to keep uniform conditions for recording the tests. All the 
subjects were given instructions and with regard to the performance of the tests. The 
tracings  in  the  spirograph  were  taken  after  being  fully  satisfied.  Two  to  three  tracings  
were taken out of which the best is taken as  the final reading.  
PROCEDURE: 
The standard spirometry maneuver is a maximal forced exhalation (greatest effort 
possible) after a maximum deep inspiration (completely full lungs). Several indices can 
be derived from this blow. 
• FVC – Forced Vital Capacity – the total volume of air that the patient can forcibly 
exhale in one breath8,9. 
• FEV1 – Forced Expiratory Volume in One Second – the volume of air that the patient is 
able to exhale in the first second of forced expiration8,9. 
• FEV1 /FVC – the ratio of FEV1 to FVC expressed as a fraction (previously this was 
expressed as a percentage). Values of FEV1 and FVC are measured in liters and are also 
expressed as a percentage of the predicted values for that individual8,9. 
MEASURING FEV1, FVC, AND FLOW–VOLUME CURVES8,9 
x Attach a clean, disposable, one-way mouthpiece to the spirometer. 
x Instruct the patient to breathe in fully until the lungs feel full. 
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x The patient should hold their breath long enough to seal their lips tightly around 
the mouthpiece. 
x Blast the air out as forcibly and fast as possible until there is no more air left to 
expel. The operator should verbally encourage the patient to keep blowing and 
keep blowing during this phase. Watch the patient  make sure a good mouth seal 
around the mouthpiece is achieved. 
x Check that an adequate trace has been achieved. Sometimes with electronic 
spirometers, the patient may leak a small volume of air into the mouthpiece while 
sealing the lips which will register as the blow. 
x Repeat the procedure at least twice until three acceptable and repeatable blows are 
obtained. Maximum of 8 efforts 
x There should be three readings, of which the best two are within 150 ml or 5% of 
each other and best. 
The  numbers appear as a table of actual and predicted figures together with volume–
time and flow–volume traces. The best readings of FEV1 and FVC are usually recorded. 
Spirometer with real-time traces and printouts are taken as they provide helpful 
information about the quality and acceptability of the blows8,9. 
INTERPRETATION OF SPIROMETRY: 
It involves looking at the absolute values of FEV1, FVC, and FEV1/FVC, 
comparing them with predicted values, and examining the shape of the spirograms. 
Patients should complete three blows that are consistent and within 5% of each other. 
In a patient with normal lung function, the volume–time curve should rise rapidly 
and smoothly and plateau within 3-4 seconds. With increasing degrees of airway 
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obstruction, it takes longer to blow out the air—up to 15 seconds—and the upward slope 
of the spirogram is much less steep8,9. 
VARIABLES UNDER THE STUDY 
In this study, a structured Proforma was used to collect clinical and laboratory 
values. The variables such as Age of the antenatal woman, gestational age in weeks, 
parity, whether they received Inj.TT and Iron Folic acid tablets, Weight (kgs), Height 
(cm), Blood Pressure and spirometric values were collected. BMI was calculated with the 
formula weight / (Height)2, Pulmonary Parameters FVC, FEV1, FEVI/FVC and PEFR 
were measured. 
 
STATISTICAL ANALYSIS: 
The data were entered in MS Excel and analyzed in SPSS software 20v. Mean 
and Standard deviations were calculated for quantitative variables and percentages for 
categorical values.  
The comparisons were assessed by one-way Analysis of Variance at 5% level of 
significance among the trimester for pulmonary parameters. Chi-square test was used to 
find the association between parity and trimester at 5% level of significance.   
The results were represented in simple tables and graphs 
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RESULTS 
Table 1: Age Distribution of Antenatal Mothers 
 
Trimester 
Chi Sq p value 
Age First Second Third Total 
<20 years 4 2 3 9 
1.43 
 
0.8 
 
21 – 30 Years 20 24 22 66 
>31 Years 6 4 5 15 
Total 30 30 30 90 
 
In this study, 90 subjects were selected considering 30 equal samples in each 
group.  Their age ranged from 18 years to 34 years overall. Table 1 describes the 
distribution of age among the three trimesters 66 subjects were in the age group of 21 
years to 30 years. There is no significant difference between the groups by chi-square test 
(p = 0.8).  
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Their mean age was described in table 2. Mean age in the first trimester was 26.1 
± 4.7, Second trimester 24.8 ± 4.4 and in the third trimester 25.13 ± 4.61. There is no 
significant difference between the groups by Analysis of variance.  (p = 0.5).  
 
 
 
 
Graph 1: Age Distribution of Antenatal Mothers 
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Table 2: Comparison of Mean age between the three trimesters  
among pregnant women 
 
Trimester Mean SD F P Value 
First 26.10 4.70 
0.654 0.5 Second 24.80 4.40 
Third 25.13 4.61 
 
 
Graph 2: Comparison of Mean age between the three trimesters 
 among pregnant women 
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Table 3: Comparison of Mean Weight (kgs) between the three 
trimesters among pregnant women 
 
Variables Trimester Mean SD F Sig. 
WEIGHT 
(Kg) 
First 54.50 7.93 
17.024 0.0001 Second 62.53 9.46 
Third 66.50 6.73 
 
Table 3 shows the anthropometric measurements such as weight Height and BMI 
were calculated. Table 3 shows the mean Weight (kgs) across the three groups. Mean 
weight 54.5 ± 7.93, 62.53 ± 9.46 and 66.5 ± 6.73 for first second and third trimesters 
respectively which showed a significant difference by One-way ANOVA (F = 17.024, p 
= 0.0001). Graph 3 explains the difference in the bar diagram. 
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Graph 3: Comparison of Mean Weight (kgs) between the three 
trimesters among pregnant women 
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Table 4: Comparison of Mean Height (cm) between the three trimesters 
among pregnant women 
 
Variables Trimester Mean SD F Sig. 
HEIGHT 
(Cm) 
First 155.87 7.48 
1.471 0.235 Second 158.77 11.04 
Third 160.03 10.07 
 
Table 4 shows the mean Height (cm) across the three groups. Mean Height 155.87 
± 7.48, 185.77 ± 11.04 and 160.03 ± 10.04 for first second and third trimesters 
respectively which showed no significant difference by One-way ANOVA (F = 1.471, p 
= 0.2). Graph 4 explains the difference in the bar diagram. 
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Graph 4: Comparison of Mean Height (cm) between the three 
trimesters among pregnant women 
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Table 5: Comparison of Mean Body Mass Index (BMI) between the 
three trimesters among pregnant women 
 
Variables Trimester Mean SD F Sig. 
BMI 
First 22.51 3.52 
6.033 0.004 Second 25.06 4.56 
Third 26.34 4.84 
 
 
Table 5 shows the mean Body Mass Index (BMI) across the three groups. Mean 
BMI were 22.51 ± 3.52, 25.06 ±4.56 and 26.34 ± 4.84 for first second and third 
trimesters respectively which showed statistically significant difference by One-way 
ANOVA (F = 6.033, p = 0.004). Graph 5 explains the differences in the bar diagram. 
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Graph 5: Comparison of Mean Body Mass Index (BMI) between the 
three trimesters among pregnant women 
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Table 6: Comparison of Mean Blood Pressure between the three 
trimesters among pregnant women 
 
BP Trimester Mean SD F Sig. 
SBP 
First 123.30 11.26 
8.196 0.001 Second 131.07 6.22 
Third 121.07 11.71 
DBP 
First 78.70 6.82 
14.962 0.0001 Second 84.97 3.76 
Third 75.87 8.35 
 
Table 6 shows the mean Blood Pressures among the three group study subjects. 
Mean Systolic Blood Pressure 123.3 ± 11.26, 131.07 ± 6.22 and 121.07 ± 11.71 for first 
second and third trimesters respectively which showed statistically significant difference 
by One-way ANOVA (F = 8.196, p = 0.001).   
Mean Diastolic Blood Pressure were 78.7 ± 6.82, 84.97 ± 3.76 and 75.87 ± 8.35 
for first second and third trimesters respectively which showed statistically significant 
difference by One-way ANOVA (F = 14.962, p = 0.0001). Graph 6 and 7 explains the 
differences in Blood Pressures as bar diagrams 
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Graph 6: Comparison of Mean Blood Pressure between the three 
trimesters among pregnant women 
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Table 7: Comparison of Parity between the three trimesters  
among pregnant women 
 
Trimester 
Chi Sq p value 
Parity First Second Third Total 
One 14 18 13 45 
2.73 0.6 
Two 14 10 16 40 
Three 2 2 1 5 
Total 30 30 30 90 
 
Table 7 describes the difference in study groups by parity which was not 
statistically significant with chi-square test (p = 0.6). Table 8 shows subjects received 
Injection TT and Iron-folic acid tablets during their follow ups. All the subjects were 
getting according to their gestational age. Graph 8 explains with pie / doughnut diagram. 
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Graph 7: Comparison of Parity between the three trimesters  
among pregnant women 
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Table 8: Comparison of TT / IFT between the three trimesters 
 among pregnant women 
Trimester First Second Third 
Injection  TT 
 
30 30 
Iron Folic Acid Tablets 30 30 30 
 
 
Graph 8: Comparison of TT / IFT between the three trimesters among 
pregnant women 
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Table 9: Comparison of FVC (%) between the three trimesters  
among pregnant women 
 
Variables Trimester Mean SD F Sig. 
FVC % 
First 93.37 6.14 
3.501 0.034 Second 94.23 6.70 
Third 97.53 6.45 
 
Table 9 shows the mean FVC% values among the three group study subjects. 
Mean FVC values were 93.37 ± 6.14, 94.23 ± 6.7 and 97.53 ± 6.45 for first second and 
third trimesters respectively which showed statistically significant difference by One-way 
ANOVA (F = 3.501, p = 0.034).  Graph 9 explains the differences in the bar diagram. 
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Graph 9: Comparison of FVC (%) between the three trimesters  
among pregnant women 
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Table 10: Comparison of FEV1(%) between the three trimesters 
among pregnant women 
 
Variables Trimester Mean SD F Sig. 
FEV1 % 
First 91.13 8.14 
3.367 0.039 Second 91.63 9.00 
Third 96.00 6.66 
 
Table 10 shows the mean FEV1% values among the three group study subjects. 
Mean FEV1 values were 91.13 ± 8.14, 91.63 ± 9 and 96 ± 6.66 for first second and third 
trimesters respectively which showed statistically significant difference by One-way 
ANOVA (F =3.367, p = 0.039).  Graph 10 explains the differences in the bar diagram. 
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Graph 10: Comparison of FEV1(%) between the three trimesters  
among pregnant women 
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Table 11: Comparison of FEV1/ FVC(%) between the three trimesters 
among pregnant women 
 
Variables Trimester Mean SD F Sig. 
FEV1/FVC 
( %) 
First 91.84 6.32 
4.904 0.01 Second 93.19 6.47 
Third 96.66 5.64 
 
Table 11 shows the mean FEV1/ FVC% values among the three group study 
subjects. Mean FEV1/FVC% values were 91.84 ± 6.32, 93.19 ± 6.47 and 96.66 ± 5.64 for 
first second and third trimesters respectively which showed statistically significant 
difference by One-way ANOVA (F = 4.904, p =0.01).  Graph 11 explains the differences 
in the bar diagram. 
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Graph 11: Comparison of FEV1/FVC (%) between the three trimesters 
among pregnant women 
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Table 12: Comparison of PEFR between the three trimesters  
among pregnant women 
 
Variables Trimester Mean SD F Sig. 
PEF 
First 99.15 4.62 
9.965 0.0001 Second 100.51 5.49 
Third 104.80 5.21 
 
Table 13 shows the mean PEFR values among the three group study subjects. 
Mean PEFR values were 99.15 ± 4.62, 100.51 ± 5.49 and 104.8 ± 5.21 for first second 
and third trimesters respectively which showed statistically significant difference by One-
way ANOVA (F = 9.965, p =0.0001).  Graph 13 explains the differences in bar diagram 
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Graph 12: Comparison of PEFR between the three trimesters 
 among pregnant women 
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DISCUSSION 
The present cross-sectional study had an equal number of samples in three-
trimester groups group 1:up to 12 weeks, group 2 :13weeks to 28 weeks and group 3: 29 
weeks  to term. Most of the subject participants were in the mean age of 20 to 30 years. 
The anthropometric measures weight, Height, and BMI were calculated. Height not 
having any significant difference where in weight and BMI were statistically differing in 
each  trimester.  As  gestational  age  increases,  there  is  a  rise  in  weight  and  BMI  which  
correlating with previous studies as well. 
During pregnancy, caloric intake increases to make the sure proper development 
of the fetus. The amount of weight gained during a single pregnancy varies among 
women. The overall pregnancy weight gain for women starting pregnancy at a normal 
weight, with a BMI of 18.5 - 24.9 range from 11.4 to15.9 kg32 
Gestational weight is a unique and complex biological phenomenon that supports 
the functions of growth and development of the foetus. Gestational weight gain is 
influenced not only by alterations in maternal physiology and metabolism but also by 
placental metabolism. The placenta functions as an endocrine organ, a barrier, and a 
transporter of substances between maternal and fetal circulation. Practitioners may 
formulate different recommendations based on specific and individualized patient`s 
needs, based on factors including low maternal age, nutritional status, foetal 
development, and morbid obesity. During the antenatal period, insufficient or excessive 
weight gain can compromise the health of the mother and fetus and also affect respiratory 
function. 
 55 
 
The blood pressures both systolic and diastolic were also showed significant 
difference due to the trimesters. There were increases in the second trimester, third-
trimester values more or less equal to first by Tukey’s multiple comparison tests.  
In  respiratory  parameters,  there  was  rising  trend  across  the  three  trimesters  of  
FVC%, FEV1%, EFR and PEF values. Similar studies showed raise in these values. 
These were due to the downward movement of the uterus, as the head of the fetus gets 
engaged. It is generally observed that the breathlessness seen in the 3rd trimester of 
antenatal period disappears near full term. This finding is consistent with other authors8, 9 
PEFR was significantly increased in group 3 antenatal women. As PEFR is 
muscular element it could be because of downward displacement of the diaphragm at full 
term pregnancy. This finding is  in agreement with other researchers10 At the same time 
some  authors have found that PEFR decreases throughout pregnancy6,7,11 
Some studies showed a significant increase in Forced Vital Capacity (FVC) while 
other studies  showed a decline in FVC. They noticed a small but definite increase in the 
vital capacity curve during the antenatal period from the third to the eighth month. They 
observed, rise in the Vital Capacity during the last month of antenatal period20, 21.  
Landt CK, Widlund G and Benjamin PR found a rise in Vital Capacity during the 
antenatal period. Root , Cohen , Landt and others concluded that the Vital Capacity of the 
lung is raised during pregnancy and the rise in VC noticed6. Rubin et al observed that 
there is a decrease in Vital Capacity while Cugell  felt that Vital Capacity remained 
unchanged during pregnancy6. Howard G Knuttgen and Kendall E  studied the 
physiological changes during normal pregnancy. Pulmonary hyperventilation developed 
early in pregnancy and persisted at rest which was due to increase in Tidal Volume6. 
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Bernard J, Gee L , Bernard S Packer et al, studied about the Pulmonary 
Mechanics during Pregnancy. They noticed that during late pregnancy, there is a 25% 
decrease in FRC and about 40% decrease in ERV. The slight and statistically 
insignificant decrease in total lung capacity and VC were also found in their study6. FVC 
is maintained by the rise in inspiratory capacity.  
The work was done by the study of Skandan KP, Mehta YB, Shah V, Parikh SR 
et al showed an increase in Tidal Volume (TV) together with a decline in Expiratory 
Reserve Volume (ERV) and Vital Capacity during antinatal period. Gazioglu K, 
Kaltreider NL, Lehmann V and Fabel H found that during the antenatal period the 
Inspiratory Capacity rises and the expiratory capacity is declines6.  
Knox AJ, Petkova S et al, noticed a number of physiological alterations which 
occurred during the antenatal period. At the end of the first trimester, Ventilation rose by 
20-25% and was sustained throughout antenatal period6. A decline in the Residual 
Volume (RV) and Functional Residual Capacity (FRC) was noticed. Also, Diaphragmatic 
excursion, Vital Capacity, and Total Lung Capacity remained unchanged6. 
It would have been more suitable if patients were recruited in the 1st trimester and 
longitudinally followed up to delivery and six weeks postpartum to make sure of the 
actual time it will take for these alterations to come back to normal. Moreover,  
percentage oxygen saturation should have been obtained during the time of the study.  
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SUMMARY AND CONCLUSION 
The present study proved that the respiratory parameters are significantly altered 
during pregnancy.  
The increased FVC, PEFR, FEV1, and  FEV1/FVC ratio is a strong indication 
that pregnancy causes physiological adaptation in the lungs. Hormones determine 
changes in smooth muscle tone and possibly connective tissue - elastance might occur 
during pregnancy which probably alters the mechanical properties of the respiratory 
system.  
FVC increases significantly during the second trimester of gestation and 
throughout pregnancy. FEV1/FVC% is significantly higher in Second and the third 
trimester multiparous than primigravida women, suggesting that changes in FVC 
occurring during pregnancy persist postpartum. PEFR increases significantly during 
healthy pregnancies and should be interpreted cautiously in pregnant women with 
impaired lung function 
 With the combination of increased oxygen consumption and the decreased 
expiratory reserve volume due to the reduced functional residual capacity, rapid fall in 
arterial oxygen tension despite careful maternal positioning and pre-oxygenation may 
occur during labour and spinal anesthesia. Even with short periods of apnea, either from 
obstruction of the airway or inhalation of a hypoxic mixture of gasses, the gravida has 
little defense against the development of hypoxia.  
Pregnant women with respiratory disorders should undergo lung function test 
during labour to ascertain the degree of severity and to institute appropriate intervention. 
These will go a long way in reducing maternal mortality and morbidity and hasten the 
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attainment of Millennium Developmental goal 5 (Reduction in maternal mortality by 75 
% by the year 2015). 
Limitations of this study were the sample size which is small for cross-sectional 
studies. Future studies need to do with large sample size and if funds and time feasible 
then longitudinal studies would be better.  PFT should be a part of the routine antenatal 
checkup to prevent any possible respiratory complication. 
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PATIENT CONSENT FORM 
 
Title of the study : ASSESSMENT OF PULMONARY FUNCTION BY SPIROMETRY 
IN ANTENATAL CASES 
Name :        Date  : 
Age :        OP No  : 
Sex :                 Individual ID No:             
: 
The details of the study have been provided to me in writing and explained to me in my 
own language. 
I confirm that I have understood the above study and had the opportunity to ask 
questions. 
I understand that my participation in the study is voluntary and that I am free to withdraw 
at any time, without giving any reason, without the medical care that will normally be 
provided by the hospital being affected. 
I agree not to restrict the use of any data or results that arise from this study provided 
such a use is only for the scientific purpose(s). 
I have been given an information sheet giving details of the study. 
I fully consent to participate in the above study.   
 
 
SIGNATURE OF PARTICIPANT   SIGNATURE OF INVESTIGATOR 
 
 
 67 
 
Ra xg;Gjy; gbtk; 
 
Ma;T nra;ag;gLk; jiyg;G : BƫLH ]LzB¶tBXK    
¤_O9O ]DNIYP} 
LƬ^DXI_K 
Ma;T nra;ag;gLk; ,lk; : BLB TJXNBX M¯{¢T BµƬ 
 
gq;F ngWNthhpd; ngah; : 
 
gq;F ngWNthhpd; taJ :  gq;F ngWNthhpd; vz; : 
 
  
 NkNy Fwpg;gpl;Ls;s kUj;Jt Ma;tpd; tpguq;fs; vdf;F 
tpsf;fg;gl;Ls;sJ.  ehd; ,t;tha;tpy; jd;dpr;irahf gq;Nfw;fpd;Nwd;.  ve;j 
fhuzj;jpdhNyh ve;j rl;lr;rpf;fYf;Fk; cl;glhky; ehd; ,t;tha;tpy; ,Ue;J 
tpyfpf; nfhs;syhk; vd;Wk; mwpe;J nfhz;Nld;. 
 
 ,e;j Ma;T rk;ge;jkhfNth ,ij rhh;e;J NkYk; Ma;T Nkw;nfhs;Sk; 
NghJk; ,e;j Ma;tpy; gq;FngWk; kUj;Jth; vd;Dila kUj;Jth; vd;Dila 
kUj;Jt mwpf;iffis ghh;g;gjw;F vd; mDkjp Njit ,y;iy vd mwpe;J 
nfhs;fpNwd;.  ,e;j Ma;tpd; %yk; fpilf;Fk; jftiyNah KbitNah 
gad;gLj;jpf; nfhs;s kWf;f khl;Nld;. 
 
 ,e;j Ma;tpy; gq;F nfhs;s xg;Gf; nfhs;fpNwd;.  ,e;j Ma;it 
Nkw;nfhs;Sk; kUj;Jt mzpf;F cz;ikAld; ,Ug;Ngd; vd cWjpaspf;fpNwd;. 
 
 
 
 
gq;Nfw;gthpd; ifnahg;gk;    rhl;rpahshpd; ifnahg;gk; 
 
,lk;:        ,lk;: 
Njjp:        Njjp: 
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PROFORMA FOR PATIENT DETAILS 
 
NAME: 
AGE   :                                  D.O.B: 
OP.NO.: 
INDIVIDUAL ID. NO: 
ADDRESS: 
HISTORY:  
                      LMP:                           EDD 
                      GRAVIDA:         PARA:           LIVE:            ABORTION:               
PAST HISTORY : 
 
FAMILY HISTORY: 
DRUG HISTORY:                                                   
IMMUNISATION: 
IRON & FOLIC ACID SUPPLEMENTATION:       
GENERAL EXAMINATION: 
 
HEIGHT: 
WEIGHT: 
BMI: 
BLOOD PRESSURE:                           
SYSTEMIC EXAMINATION 
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S.NO Trimester NAME AGE Parity SBP DBP TT/IFT WT (Kg) 
HT 
(Cm) BMI 
FVC 
(Lit) 
FVC 
% 
FEV1 
(Lit) 
FEV1 
% 
FEV1/FVC 
( %) 
1 1 SRILAKSHMI GAYATHIRI 22 1 110 70 1 63 163 23.7 2.74 95 2.52 99 92 
2 1 GAYATHRI 27 2 120 80 1 50 150 22.2 2.76 107 2.43 104 93 
3 1 BRINDHA 18 1 120 70 1 38 158 15.2 2.7 90 2.25 86 99 
4 1 VINODHINI 20 1 130 90 1 40 150 17.8 2.74 101 2.31 98 84.3 
5 1 SANMATHI 21 1 130 80 1 50 155 20.8 3.07 106 2.59 103 84.4 
6 1 SHABANA 22 1 120 80 1 72 152 31.2 2.28 82 2.04 84 106 
7 1 VIJAYA 26 2 110 80 1 62 164 23.1 3.08 96 2.78 99 90.3 
8 1 MAGESHWARI 26 2 126 80 1 63 155 26.2 2.53 88 2.26 90 106 
9 1 RATHIKA 27 1 130 90 1 65 164 24.2 2.91 91 2.41 87 99 
10 1 VIJAYALAKSHMI 28 2 130 80 1 75 150 33.3 2.02 77 1.81 79 107 
11 1 DHAKSHAYINI 30 2 120 80 1 57 154 24 2.34 85 1.98 83 101 
12 1 VANTHY 30 2 130 80 1 55 148 25.1 2.51 100 2.06 94 98 
13 1 POONGKODI 31 2 120 70 1 57 156 23.4 2.58 92 1.99 82 93 
14 1 SUDHA 32 2 120 80 1 73 165 26.8 2.6 83 2.25 83 86.5 
15 1 JAYANTHI 22 2 130 90 1 71 158 28.4 2.22 78 1.95 79 87.8 
16 1 RADHIKA 32 2 120 70 1 71 156 29.2 2.66 96 2.16 90 98 
17 1 KAVITHA JAYARAMAN 34 2 130 81 1 80 154 33.7 2.03 77 1.61 70 80.1 
18 1 KAVITHA 24 1 120 70 1 52 147 24.1 2.08 87 1.75 85 84.1 
19 1 BAVITHRA 34 2 130 90 1 68 182 25.5 2.7 91 2.17 84 97 
20 1 SENTHAMIL 25 1 130 80 1 79 151 34.6 1.88 75 1.71 79 91 
21 1 PERIYAMMAL 30 1 120 80 1 52 145 24.7 2.5 110 2.13 109 103 
22 1 RADHA 26 1 120 80 1 63 155 26.2 2.53 88 2.26 90 106 
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S.NO Trimester NAME AGE Parity SBP DBP TT/IFT WT (Kg) 
HT 
(Cm) BMI 
FVC 
(Lit) 
FVC 
% 
FEV1 
(Lit) 
FEV1 
% 
FEV1/FVC 
( %) 
23 1 RADHIKA 27 1 130 80 1 65 164 24.2 2.91 91 2.41 87 99 
24 1 VANAJARANI 31 2 120 80 1 57 156 23.4 2.58 92 1.99 82 93 
25 1 NIVETHA 21 1 120 80 1 50 155 20.8 3.07 106 2.59 103 84.4 
26 1 SANGEETHA 30 2 150 80 1 55 148 25.1 2.51 100 2.06 94 98 
27 1 DHAYA 22 1 133 80 1 63 163 23.7 2.74 95 2.52 99 92 
28 1 DEVI  27 2 140 80 1 50 150 22.2 2.76 107 2.43 104 93 
29 1 SHAKTHI 18 1 100 70 1 38 158 15.2 2.7 90 2.25 86 99 
30 1 KEERTHANA 20 1 90 60 1 40 150 17.8 2.74 101 2.31 98 84.3 
31 2 RATHIKA 34 2 130 90 1 80 154 33.7 2.03 77 1.61 70 80.1 
32 2 RANI 22 1 130 80 1 72 152 31.2 2.28 82 2.04 84 106 
33 2 POONGKODI 26 2 140 90 1 62 164 23.1 3.08 96 2.78 99 90.3 
34 2 SHAMUGI 34 2 140 89 1 68 182 25.5 2.7 91 2.17 84 97 
35 2 VENI 22 1 136 88 1 71 158 28.4 2.22 78 1.95 79 87.8 
36 2 NAYAGI 28 2 126 81 1 75 150 33.3 2.02 77 1.81 79 107 
37 2 RENUGA 30 2 130 85 1 57 154 24 2.34 85 1.98 83 101 
38 2 MONISHA 25 1 126 84 1 79 151 34.6 1.88 75 1.71 79 91 
39 2 SOWNDARI 30 2 131 85 1 52 145 24.7 2.5 110 2.13 109 103 
40 2 ARCHANA 32 2 129 85 1 73 165 26.8 2.6 83 2.25 83 86.5 
41 2 RAJEE 24 1 124 84 1 52 147 24.1 2.08 87 1.75 85 84.1 
42 2 RAJALAKSHMI 32 2 132 86 1 71 156 29.2 2.66 96 2.16 90 98 
43 2 VANI 21 1 140 90 1 70 155 29.14 2.08 87 1.75 85 84.1 
44 2 NITHIYA 24 1 128 82 1 34 153 14.52 2.7 91 2.17 84 97 
45 2 MAHESWARI 24 1 132 86 1 75 168 26.57 2.74 101 2.31 98 84.3 
46 2 MOHANA 21 1 140 86 1 54 148 24.65 2.5 110 2.13 109 103 
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S.NO Trimester NAME AGE Parity SBP DBP TT/IFT WT (Kg) 
HT 
(Cm) BMI 
FVC 
(Lit) 
FVC 
% 
FEV1 
(Lit) 
FEV1 
% 
FEV1/FVC 
( %) 
47 2 VASUGI 23 1 138 88 1 70 166 25.40 2.53 88 2.26 90 106 
48 2 PAVITHRA 22 1 130 85 1 50 174 16.51 2.5 110 2.13 109 103 
49 2 SUGUMARI 19 1 126 82 1 78 170 26.99 2.58 92 1.99 82 93 
50 2 LOGANAYAGI 21 1 125 85 1 50 165 18.37 2.66 96 2.16 90 98 
51 2 RENUGA 21 1 130 85 1 51 155 21.23 2.51 100 2.06 94 98 
52 2 PRIYA 24 2 130 85 1 52 148 23.74 2.74 95 2.52 99 92 
53 2 MARGRET 24 1 138 88 1 38 134 21.16 2.5 110 2.13 109 103 
54 2 TINU 21 1 135 85 1 64 176 20.66 2.7 90 2.25 86 99 
55 2 DANYA 23 1 136 86 1 58 166 21.05 2.74 101 2.31 98 84.3 
56 2 RASHMITHA 22 1 132 85 1 52 172 17.58 2.66 96 2.16 90 98 
57 2 FLORA 19 1 130 84 1 56 175 18.29 2.28 82 2.04 84 106 
58 2 AMBIKA 21 2 128 85 1 50 148 22.83 2.74 101 2.31 98 84.3 
59 2 LAKSHMI 25 2 130 85 1 64 157 25.96 2.7 91 2.17 84 97 
60 2 SANJANA 30 2 110 70 1 67 155 27.89 2.53 88 2.26 90 106 
61 3 FATHIMA 32 2 130 82 1 52 150 23.11 2.74 95 2.52 99 92 
62 3 ESWARI 24 2 128 78 1 47 146 22.05 2.03 77 1.61 70 80.1 
63 3 SONA 32 2 128 86 1 50 150 22.22 2.76 107 2.43 104 93 
64 3 GAYATHRI 21 1 114 76 1 57 163 21.45 2.91 91 2.41 87 99 
65 3 LAKSHANA 24 2 108 74 1 53 154 22.35 2.74 101 2.31 98 84.3 
66 3 RITHANI 24 1 134 84 1 54 153 23.07 2.76 107 2.43 104 93 
67 3 ABIRAMI 25 2 148 96 1 52 151 22.81 3.07 106 2.59 103 84.4 
68 3 RAJESHWARI 30 1 108 68 1 50 160 19.53 2.76 107 2.43 104 93 
69 3 SUMITHRA 26 2 106 70 1 50 143 24.45 2.03 77 1.61 70 80.1 
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S.NO Trimester NAME AGE Parity SBP DBP TT/IFT WT (Kg) 
HT 
(Cm) BMI 
FVC 
(Lit) 
FVC 
% 
FEV1 
(Lit) 
FEV1 
% 
FEV1/FVC 
( %) 
70 3 KANIMOZHI 22 2 110 70 1 51 161 19.68 2.5 110 2.13 109 103 
71 3 SNEHA 19 1 110 68 1 60 149 27.03 2.76 107 2.43 104 93 
72 3 VIDYA 21 1 124 70 1 30 170 10.38 3.08 96 2.78 99 90.3 
73 3 SINTHUJA 34 2 120 72 1 60 166 21.77 2.28 82 2.04 84 106 
74 3 ROWENA 22 2 118 70 1 67 163 25.22 2.7 91 2.17 84 97 
75 3 SAMUNDEESWARI 27 2 124 70 1 73 172 24.68 1.88 75 1.71 79 91 
76 3 VANITHA 21 1 120 60 1 78 152 33.76 2.7 90 2.25 86 99 
77 3 RAMYA 27 2 128 78 1 60 156 24.65 2.74 95 2.52 99 92 
78 3 SUDHA 31 2 124 70 1 66 174 21.80 2.53 88 2.26 90 106 
79 3 SUMATHY 21 1 126 80 1 58 149 26.12 2.7 90 2.25 86 99 
80 3 DHARANI 30 2 110 70 1 64 182 19.32 2.74 101 2.31 98 84.3 
81 3 KAVITHA 22 1 130 82 1 70 165 25.71 2.08 87 1.75 85 84.1 
82 3 LATHA 27 2 128 78 1 66 167 23.67 2.53 88 2.26 90 106 
83 3 VINODHINI 18 1 128 86 1 53 146 24.86 1.88 75 1.71 79 91 
84 3 ASHWINI 20 1 114 76 1 70 178 22.09 2.76 107 2.43 104 93 
85 3 UMA 34 2 108 74 1 60 166 21.77 2.28 82 2.04 84 106 
86 3 MALAR 24 2 134 84 1 66 170 22.84 3.08 96 2.78 99 90.3 
87 3 VINEETHAYA 21 1 148 96 1 64 163 24.09 2.28 82 2.04 84 106 
88 3 KIRUTHIKA 23 1 108 68 1 61 160 23.83 2.91 91 2.41 87 99 
89 3 KALAI 22 1 106 70 1 73 166 26.49 3.08 96 2.78 99 90.3 
90 3 SHYNEE 30 2 110 70 1 64 156 26.30 2.74 101 2.31 98 84.3 
 
